Frankfurt am Main, Germany

Klaus Steinmeyer



 

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Klaus Steinmeyer: Innovator in Pharmaceutical Chemistry

Introduction

Klaus Steinmeyer is a prominent inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific potassium channels. With a total of five patents to his name, Steinmeyer is recognized for his innovative approaches to treating various medical conditions.

Latest Patents

Steinmeyer's latest patents include the invention of fused pyrroledicarboxamides and their use as pharmaceuticals. This invention relates to compounds that act as inhibitors of the acid-sensitive potassium channel TASK-1. These compounds are particularly suitable for treating TASK-1 channel-mediated diseases, such as arrhythmias, including atrial fibrillation and atrial flutter, as well as respiratory disorders like sleep apnea. Another notable patent involves substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, which are also designed to act on the TASK-1 potassium channel. These compounds are aimed at the treatment or prevention of atrial arrhythmias, further showcasing Steinmeyer's commitment to advancing medical science.

Career Highlights

Klaus Steinmeyer is currently employed at Sanofi, a leading global biopharmaceutical company. His work at Sanofi has allowed him to focus on innovative drug development, contributing to the advancement of therapeutic options for patients worldwide. His expertise in pharmaceutical chemistry has positioned him as a key player in the industry.

Collaborations

Steinmeyer has collaborated with notable colleagues, including Laurent Bialy and Klaus Wirth. These collaborations have fostered a productive environment for research and development, leading to significant advancements in their respective fields.

Conclusion

Klaus Steinmeyer is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of innovative treatments for serious medical conditions. His contributions continue to impact the field positively, demonstrating the importance of research and collaboration in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…